Associated Papers
Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer.
Yamashita H et al.
Cancers, 2024
38893118 (PubMed )
Supplement: cancers-16-01999-s001.zip › cancers-2994449-supplementary.pdf
Select a paper to view details